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Attachment of ubiquitin (Ub) as monoUb and polyUb chains of different lengths and linkages to proteins
plays a dominant role in very different regulatory mechanisms. Therefore, the study of polyUb chains has
assumed a central interest in biochemistry and structural biology. An essential step necessary to allow
in vitro biochemical and structural studies of polyUbs is the production of their chains in high quantities
and purity. This is not always an easy task and can be achieved both enzymatically and chemically.
Previous reviews have covered chemical cross-linking exhaustively. In this review, we concentrate on the
different approaches developed so far for the enzymatic production of different Ub chains. These stra-
tegies permit a certain ﬂexibility in the production of chains with various linkages and lengths. We
critically describe the available methods and comment on advantages and limitations. It is clear that the
ﬁeld is mature to study most of the possible links, but some more work needs to be done to complete the
picture and to exploit the current methodologies for understanding in full the Ub code.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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S. Faggiano et al. / Analytical Biochemistry 492 (2016) 82e90 83Ubiquitination is one of the most important post-translational
modiﬁcations because it is involved in several essential cellular
pathways [1e3]. It arises from the ability of ubiquitin (Ub) to cross-
link either with another Ub or with different proteins and form a
covalent bond between the C-terminal carboxyl group of glycine 76
of Ub and the ε-amino group of a target protein lysine side chain
(Fig. 1A). When cross-linking occurs between two Ub molecules
conventionally, during the formation of an isopeptide bond, the
proximal Ub is the one linked through the lysine residue, whereas
the Ub linked by the C-terminal glycine is called distal Ub. Because
Ub has seven lysines, it can form eight structurally and functionally
distinct chain types in which Ub moieties are linked via one of the
seven Lys residues or the amino terminus [2]. This leads to chains
with any of the following linkages: Met1, Lys6, Lys11, Lys27, Lys29,
Lys33, Lys48, and Lys63 [4] (Fig. 1B). Chains with mixed linkages
and branched chains have also been identiﬁed in vivo [5,6].
Different linkages have different functional speciﬁcities [7]. Lys48-
and Lys63-linked polyUb chains are linked to protein degradation
[8] and cellular signaling [9], whereas the role of the remaining Ub
chain types, often indicated as “atypical” chains, is less understood
[10]. Lys11 and Met1 linkages seem to be involved in cell cycleFig.1. (A) Scheme of the formation of an isopeptide bond between two Ub molecules.
(B) Tridimensional structure of ubiquitin (PDB code 1UBQ). All seven lysines, plus the
N-terminal methionine and the C-terminal glycine, are labeled.regulation and nuclear factor-kB activation, respectively [11,12].
Unanchored Ub chains cause the activation of protein kinases as
TAK1 and IKK [13,14]. It is likely that other new roles in cells will be
unveiled.
Ubiquitination is catalyzed in vivo by a three-step enzymatic
cascade. An E1 Ub activating enzyme, in the presence of adenosine
triphosphate (ATP), transfers Ub to the active site cysteine of a E2
Ub conjugating enzyme [15e17]. E2 then directly transfers Ub to a
lysine of the substrate, oftenwith the help of an E3 Ub ligase [18], or
performs a transthiolation by transferring Ub to the active site
cysteine of an E3 enzyme, which is responsible for the ubiquiti-
nation of the substrate [19]. The presence of awide set of speciﬁc E2
and E3 enzymes accounts for the ﬁne tuning and complexity of Ub
signaling [20].
To unveil the molecular mechanisms responsible for the in vivo
effects of protein ubiquitination, it is necessary to produce large
quantities of pure samples of ubiquitinated proteins and Ub chains
for a biochemical, biophysical, and structural characterization.
Ubiquitination has been obtained either by chemical synthesis of
suitable functionalized precursors or by enzymatic assembly.
Several strategies have been proposed for the enzymatic produc-
tion of monoubiquitinated proteins at high yields [21]. A recent
article also described a new method to obtain polyubiquitinated
proteins [22].
Here, we concentrate on the problem of producing polyUb
chains. DiUbs of all eight possible types are commercially available
(Life Sensors, Boston Biochem, Enzo Life Sciences). Longer K48-,
K63-, and K11-linked and linear chains are also available, but the
requirement of milligrams of sample makes the elevate cost pro-
hibitive. Luckily, production of Ub chains is relatively less complex
than synthetizing ubiquitinated proteins; Ub is a very stable protein
that can be easily refolded, allowing the possibility to work in
denaturing conditions for the chemical synthesis of the chains.
Alternatively, the speciﬁc enzymes for the formation of most Ub
chain types are also known and well characterized, allowing an
enzymatic procedure.
Several chemical or enzymatic approaches have been devel-
oped. Chemical methods are generally based on the preparation of
reactive precursors that are ligated by native chemical ligation.
Because these non-enzymatic methods have been amply reviewed
before, we refer the reader to previous publications for details
[23e25]. In this review, we focus on the strategies developed for
the enzymatic synthesis of polyUb chains of selected lengths and
linkages. The main two approaches developed differ for the Ub
substrate used, either Ubmutants or wild-type Ub. We describe the
methods developed so far and provide examples of applications for
different chain types.
Production of polyUb chains using Ub mutants
A rather convenient enzymatic method for the production of
K48-linked Ub chains of selected length was reported in 1997 by
Pickart and coworkers [26]. The method was later extended to K63-
linked chains, and detailed protocols were published [27,28]. It
relies on the ability of an E2 Ub conjugating enzyme to form a
speciﬁc type of isopeptide bond between two Ub molecules. An E1
enzyme activates Ub for the reaction, and the speciﬁc E2 catalyzes
the conjugation. ATP is consumed to form the charged E1. Speci-
ﬁcity for a given chain type is achieved by the choice of a speciﬁc E2
(or E2/E3 couple). Two Ub reactants are used: one reversibly cap-
ped at its C terminus and the other blocked at its lysine site. The
authors deﬁned as the “proximal end” of a chain an unconjugated
G76 residue because it serves for the attachment of a proximal Ub
residue. Accordingly, the “distal end” of a chain is the unconjugated
lysine residue (Fig. 2A). The Ub mutant blocked at the proximal site
S. Faggiano et al. / Analytical Biochemistry 492 (2016) 82e9084(also referred to as proximally blocked Ub) is Ub-D77 because the
presence of an extra amino acid after G76 impairs conjugation
through the C terminus of a proximal Ub. The distally blocked Ub is
obtained by mutating to cysteine or arginine the lysine involved in
the formation of the speciﬁc chain type by the selected E2, so that
the covalent binding of a distal Ub is impaired. For example, in the
case of K48-linked chains, recombinant E2-25K, able to speciﬁcally
form K48-linked chains, is used to catalyze the reaction between
equal amounts of Ub-D77 and Ub-K48C mutants (Fig. 2B). Thus,
diUb is formed in almost equimolar concentration with respect to
the monoUb reactants. The reaction will not proceed with the
formation of longer chains unless the doubly blocked diUb is
conveniently deprotected. A puriﬁcation step (often cation ex-
change chromatography) will separate the product from unreacted
Ub molecules.
The use of Ub mutants has some advantages with respect to the
production of Ub chains using wild-type Ub. The elongation of the
chain is controlled step by step. Hence, it allows differentiating
between the different positions on the chain. Thus, it is possible to
apply a differential isotope labeling scheme for the different Ub
monomers to obtain precise structural information on the inter-
action of each monomer in the chain with a protein partner
[29e31]. This method also permits inserting a mutated Ub in a
precise position of the chain [32]. On the other hand, producing Ub
mutants is more laborious than using commercial wild-type Ub,
and the introduction of mutations might have some yet unde-
scribed effects on the properties of the chains.
Deblocking of the proximal or distal terminus is necessary to
form longer chains. The yeast protease Ub hydrolase-1 (YUH1) is
able to remove the D77 proximal cap, forming a proximallyFig.2. (A) Scheme of K48-linked diUb. Chain elongation can occur at the “proximal
end” on binding of a proximal Ub or at the “distal end” on covalent conjugation of a
distal Ub. (B) Production of K48-linked diUb using Ub mutants.deblocked moiety. Treatment with ethyleneimine allows the
alkylation of C48 to form an S-aminoethylcysteine, carrying a ter-
minal amino group that mimics a lysine residue and reacts as
distally deblocked moiety. K48-linked triUb, for example, can be
prepared incubating proximally deblocked diUb with Ub-D77 in
the presence of E1 and E2-25K. Similarly, K48-linked tetraUb is
obtained by enzymatic ligation of two single proximally and
distally deblocked diUb molecules. Appropriate use of single-
capped substrates for rounds of deblocking and conjugation
potentially allows the preparation of chains of any desired length.
The efﬁciency of the next conjugation step depends on the efﬁ-
ciency of deblocking of the capped product, which is approximately
80e90% for the YUH1 reaction and 75e90% for the ethyleneimine
reaction [27]. When a chain is conjugated with a monomer, such as
in the production of triUb, a 10% stoichiometric excess of the
monomer reactants helps to force complete ligation of the chain
and, thus, to improve the resolution in the puriﬁcation step [27]. For
longer chains, the separation of the product from reactants having
similar length might be a problem because the resolution obtained
by cation exchange is lower. Thus, it is better to use two precursors
of similar size so that the unreacted chains can more easily be
separated from the products (e.g., it is better for producing Ub12 to
ligate Ub6 with Ub6 or Ub8 with Ub4 rather than Ub10 with Ub2).
Synthesis of K48- and K63-linked chains
The two reactants, Ub-D77 and the speciﬁc mutant of lysine to
cysteine or arginine (i.e., Ub K48C or K48R), are produced in
Escherichia coli as untagged proteins [27]. The proteins are very
stable and expressed in high amounts, allowing the production of
50e100 mg of puriﬁed proteins per liter of culture. Ub is easily
puriﬁed thanks to its solubility in acid conditions. Perchloric acid
(0.5%) is added to the cell lysate, causing most of the other proteins
to precipitate, whereas Ub remains soluble in the supernatant.
Further puriﬁcation is achieved with cation exchange chromatog-
raphy on an S-Sepharose Fast Flow resin (GE Life Sciences) run in
50 mM ammonium acetate at pH 4.5. The mutants are soluble to at
least 110 mg/ml. Regarding the enzymes for the ubiquitination, a
mammalian E1 (UBE1) expressed in insect cells infected with
baculovirus is used in the protocol proposed by Pickart and co-
workers [27,33]. Alternatively, E1 can be expressed as a recombi-
nant protein in E. coli, although insolubility and proteolytic
instability might occur because of the high molecular weight
(~110 kDa) [34]. For K48-linked chains, the E2 enzyme E2-25K (also
known as UbcH1) can be expressed as untagged protein or in a
tagged GST form [27,35]. The Mms2/Ubc13 complex is used as E2
for K63-linked chains. His-tagged Mms2 (also called UBE2V2) is
expressed in inclusion bodies, puriﬁed under mild denaturing
conditions in 4 M urea using a nickel resin, and renatured by
dialysis [36]. Ubc13 (also called UbcH13 or UBE2N) is expressed as
GST tagged [37].
The experimental conditions for the ubiquitination are reported
in Table 1. Dithiothreitol (DTT) is added to keep the enzymes
reduced, but concentrations higher than 0.5 mM must be avoided
because DTT can react with the activated E2 Ub thiol ester, thereby
reducing the efﬁciency of the catalysis. The two Ub mutants are
incubated with E1 and the speciﬁc E2 (E2-25K for K48-linked
chains or Mms2 and Ubc13 for K63-linked chains). The reaction is
carried out for 4 h at 37 C, after which 5 mM DTT and 1 mM
ethylenediaminetetraacetic acid (EDTA) are added. The mixture is
incubated for reduction for 20 min at room temperature. After
bringing the mixture to pH 4.0 with acetic acid, the precipitated E1
and E2 enzymes are eliminated by centrifugation. DiUb is separated
from unreacted monomers by cation exchange in buffer (50 mM
ammonium acetate, pH 4.5), 1 mM EDTA, and 5 mMDTT and eluted
Table 1
Experimental details for production of Ub chains using Ub mutants.
Chain type Ubiquitination mixture Reference
K48 or K63 (Pickart et al.) Substrate and enzymes: 7.5 mg/ml Ub-D77, 7.5 mg/ml K48C or K48R, 0.1 mM E1, and 20 mM E2-25K for K48-linked chains
or 8 mM each of Mms2 and Ubc13 for K63-linked chains
Buffer: 250 mM TriseHCl (pH 8.0), 2.5 mMATP, 25 mMMgCl2, 0.5 mMDTT, 50 mM creatine phosphate, 3 U/ml inorganic
pyrophosphatase, and 3 U/ml creatine phosphokinase (ATP regenerating system)
[27]
K11 (Casta~neda et al.) Substrate and enzymes: K11ReK63R Ub, K63R-D77 Ub, UbE2S
Buffer: as in Ref. [27]
[30]
K6 (Edelmann et al.) Substrate and enzymes: 25 mg Ub K48R 2.9 mM, 0.1 mM E1, 0.56 mM UbE2L3, 11.1 mM NleL
Buffer: 10 mM ATP and 10 mM MgCl2 in 40 mM TriseHCl (pH 7.5) and 0.6 mM DTT
Total volume: 1 ml
[48]
Fig.3. Strategy for the assembly of K11-linked diUb.
S. Faggiano et al. / Analytical Biochemistry 492 (2016) 82e90 85with a 0e0.6 M NaCl gradient. A slightly higher pH value (5.2) was
used for the puriﬁcation of K63-linked di- and triUb in a more
recent work [38]. Because polyUb chains tend to precipitate when
left at pH 4.5, a quick dialysis in the ﬁnal buffer is recommended. Ub
chains are also rather sticky, and the unspeciﬁc absorption to sur-
faces reduces the ﬁnal yield. Therefore, it is suggested to reuse
columns, avoid glass tubes, andmaximize protein concentrations to
increase recovery [27]. Recently, a slightly different protocol was
described for K63-linked chains in which tris(2-carboxyethyl)
phosphinewas used instead of DTTand no ATP regenerating system
was added to the mixture [39], but the ATP concentration was
increased to 15 mM.
The doubly capped diUb must be unblocked prior to chain
elongation [27]. Concentrations of 16 mg/ml YUH1 [40], the enzyme
used to cleave D77, are used for 1 h on half of the doubly blocked
diUb to form tetraUb. The proximally unblocked diUb is then pu-
riﬁed by anion exchange on a Q-Sepharose Fast Flow column. The
second half of the doubly blocked diUb is unblocked on the distal
site on reaction with ethyleneimine. After the reaction (1 h), the
alkylating agent must be dialyzed away because it can irreversibly
inactivate the E1 and E2 enzymes. At this point, the two singly
blocked diUbs are mixed using conditions similar to those used for
the ﬁrst conjugation step. Pure tetraUb is separated by cation ex-
change [27] or size exclusion chromatography [41]. When the ﬁnal
length is reached, the distal C48 can be alkylated with ethyl-
eneimine or iodoacetamide to reduce the risk of disulﬁde bond
formation and precipitation [27]. A similar protocol for the pro-
duction of K48-linked tetraUb is described in another article [42].Synthesis of K11-linked chains
Fushman and coworkers reported a structural study on K11-
linked diUb [30] based on two different strategies of sample pro-
duction: one involving the use of Ub mutants and the other one
with no mutations for comparison (see “Controlled synthesis of Ub
chains using unnatural amino acids” section below). The E2 enzyme
used to catalyze the formation of K11-linked chains is UbE2S, but
this enzyme also leads to the formation of K63 chains in small
amounts (see “Synthesis of K48- and K63-linked chains” section
below) [43,44]. To circumvent this limitation, Casta~neda and co-
workers used two double mutants: K11ReK63R Ub for the distal
moiety and K63R-D77 Ub for the proximal one (Table 1). K11R
mutation is needed to obtain the distally blocked Ub (i.e., the site
for attachment of a distal Ub is blocked); Ub-D77 mutation gives
the proximally blocked Ub, whereas K63R mutation on both Ub
mutants prevents formation of K63-linked chains (Fig. 3). This
approach allowed individual selective isotope labeling of each Ub
unit for nuclear magnetic resonance (NMR) studies. The authors
also prepared K11-linked chains with no mutations to compare the
chemical shift perturbation data of the two types of chains. Theyused genetically encoded unnatural amino acids to control Ub
polymerization by UbE2S [45].
Synthesis of K6-linked chains
Komander and coworkers suggested a protocol for the assembly
of K6-linked chains [31]. The method exploits the catalytic activity
of NleL, a newly discovered bacterial Ub E3 ligase [46]. In the
presence of E1 and UbE2L3 (also called UbcH7) [47], NleL is able to
form both K6- and K48-linked chains. The authors developed two
different strategies: they used as substrate either the Ub K48R, so
that the enzymes will univocally form K6-linked chains, or the
wild-type Ub and added to the mixture the K48-speciﬁc deubi-
quitylase (DUB) OTUB1 [48] (Fig. 4A and B). The reaction with Ub
K48R differs from the others described previously because the
mutation is introduced not to block the elongation of the K6-linked
chain but rather to impair the formation of unwanted K48-linked
chains.
When Ub K48R is used, the reaction is carried out at 37 C for
3e4 h using Ub K48R, E1, UbE2L3, and NleL (detailed conditions
shown in Table 1). The solution is acidiﬁed with 3 ml of 4 M HCl.
After centrifugation, the Ub chains are puriﬁed by size exclusion
chromatography on a Superdex 75 column (GE Healthcare) in
50 mM TriseHCl at pH 7.6. This protocol allows production of di-,
tri-, and tetraUb [31]. Speciﬁc procedures were set up to obtain K6-
linked triUb samples selectively labeled on a speciﬁc Ub moiety for
NMR experiments. To obtain a K6 triUbwith the middle Ub labeled,
diUb is ﬁrst assembled using a 1:1 molar ratio of 13C,15N-labeled Ub
K48R and unlabeled Ub K48R harboring a noncleavable C-terminal
histidine tag. This construct lacks G76 to prevent proteolysis of the
histidine tag during expression in E. coli. The diUb formed by
labeled Ub (distal) and unlabeled Ub (proximal) is puriﬁed by Ni-
Fig.4. Strategy for the production of K6-linked chains using Ub mutants (A) or wild-
type Ub and OTUB1 (B) to cleave unwanted K48-linked chains.
S. Faggiano et al. / Analytical Biochemistry 492 (2016) 82e9086NTA afﬁnity chromatography and reacted with unlabeled Ub K48R
K6R, which can ligate to the diUb through its C terminus. The triUb
product is puriﬁed by size exclusion chromatography.Production of polyUb chains using wild-type Ub
A different approach for polyUb preparation is the enzymatic
synthesis of chains of distinct length using wild-type Ub as sub-
strate. This approach was developed during the early 1990s by the
group of Pickart [49,50], who prepared K48-linked di- and tetraUb
for crystallographic studies starting from wild-type Ub.
More recently, Komander's group produced K48- and K63-
linked Ub chains using wild-type Ub [51]. The same group devel-
oped a protocol for the production of K11-linked chains [44,52].
Production of K11-, K48-, and K63-linked triUb was independently
reported by Bosanac and coworkers [53]. Later on, Hymowitz,
Dueber, and coworkers published a detailed methodological article
exploiting the same approach [43]. The method is based on the
formation of unanchored Ub chains by E1 and a speciﬁc E2 enzyme.
After a few hours at 37 C, the reaction leads to formation of a
mixture of chains of different lengths. Their separation, therefore, is
a crucial step of this protocol. The most common approach to
perform the separation is cation exchange chromatography [43,51].
This method has the advantage of producing chains of different size
in a single reaction. This can be exploited, for example, to study the
afﬁnity of Ub binding proteins with chains of increasing length.
Another advantage is that, because it does not require recombinant
Ub, the relatively cheap commercial bovine Ub can be conjugated to
obtain milligrams of polyUb chains. Two main limits are that noselective isotope labeling of a particular position in the chain is
possible because the reagents are indistinguishable Ub monomers
and that chains longer than tetraUb might be difﬁcult to be sepa-
rated by cation exchange or size exclusion chromatography. This
method requires the use of an E2 enzyme (or E2/E3 couple) speciﬁc
for a target chain type. New protocols in recent publications
describe the use of a DUB to cleave unwanted chain types formed as
secondary products, thereby enabling the production of milligrams
of K29- and K33-linked chains [54e56].
Synthesis of K48- and K63-linked chains
In Komander's approach [51], wild-type Ub is produced in E. coli
and puriﬁed similarly to previous protocols for Ub mutants [27]. E1
is produced according to Trempe and coworkers [57], whereas the
E2 used for K48-linked chains, Cdc34, which works similarly to E2-
25K, and the E2 used for K63-linked chains, Ubc13/Uev1A, are
puriﬁed according to Zhang and coworkers [58]. Lys63-linked Ub
chains are produced using wild-type Ub, E1, Ubc13, and Uev1A, also
called UBE2V1 (details shown in Table 2). Lys48-linked Ub chains
are produced with the same protocol but using Ccd34 instead of
Ubc13/Uev1A (Table 2). The ubiquitination reaction is stopped after
3 h by 20-fold dilution with 50 mM ammonium acetate (pH 4.5).
The mixture of different chains is puriﬁed using a MonoS cation
exchange chromatographic column (GE Life Sciences). Chains of
different lengths can be separated applying a shallow gradient of
0e0.6 M NaCl in 50 mM ammonium acetate (pH 4.5). This method
allows the separation of chains up to pentaUb.
A different approach set up for the production of di-, tri-, and
tetraUb was reported independently [53] and, in more details, by
researchers at Genentech [43]. Cdc34 and Ubc13-Uev1A are used
for K48- and K63-linkages, respectively [43]. In these protocols, the
enzymes are all produced in E. coli as afﬁnity-tagged proteins.Wild-
type Ub is mixed with E1 and Cdc34 or Ubc13-Uev1A for K48- or
K63-linkages, respectively (Table 2). No ATP regenerating system is
added, although the authors commented that this is compatible
with the reaction, as reported in a similar procedure for the pro-
duction of K11 chains [59]. The reaction mixture is incubated
overnight at 37 C. The amounts of the enzymes are chosen so that a
certain percentage of Ub (>30%) would remain unreacted to avoid
the risk of cyclization of Ub polymers [60]. Unincorporated Ub can
be recovered and reused anyway. As a general suggestion, the au-
thors advised paying particular attention when preparing samples
for sodium dodecyl sulfateepolyacrylamide gel electrophoresis to
check ubiquitination: samples should not be heated prior to gel
loading in order to limit formation of high molecular weight lad-
dering artifacts [43]. In addition, a nonreducing sample buffer
should be used and samples should be mixed with loading buffer
just prior to running the gel. The reaction is stopped by the addition
of a 20-fold excess of 50 mM ammonium acetate and 100 mM NaCl
at pH 4.5. Unreacted mono-, di-, tri-, and tetraUb species are
separated by cation exchange chromatography on a MonoS column
with a 0e0.6MNaCl gradient. To obtain higher amounts of tetra- or
hexaUb, it is possible to pool the diUb fraction from a ﬁrst ubiq-
uitination step, dialyze it in the ubiquitination buffer, and use it to
replace monomeric Ub as the starting material. Separation by size
exclusion chromatography is also used for ﬁnal puriﬁcation of the
distinct polyUb chain lengths, for example, using a HiLoad Super-
dex 75 column (GE Life Sciences).
Synthesis of K11-linked chains
K11-linked chains are produced from wild-type Ub in a similar
way. In Dong and coworkers' study, a truncated form of UbE2S,
UbE2SDC (M1-G156), is used as E2 (details shown in Table 2) [43].
Table 2
Experimental details for production of Ub chains using wild-type Ub.
Chain type Ubiquitination mixture Reference
K48 or K63 (Komander et al.) Substrate and enzymes for K63-linked chains: 1.4 mM wild-type Ub, 1 mM E1, 8 mM Ubc13, 8 mM Uev1A (also called
UBE2V1)
Substrate and enzymes for K48-linked chains: same protocol as for K63-linked chains but using 2.8 mM wild-type Ub and
25 mM Ccd34 instead of Ubc13/Uev1A
Buffer: 40 mM TriseHCl (pH 7.5), 10 mM ATP, 10 mM MgCl2, 0.6 mM DTT
[51]
K48 or K63 (Dong et al.) Substrate and enzymes for K63-linked chains: 50 mg of wild-type Ub 1.0e1.5 mM, 0.5 mM E1, 2.5e5.0 mM Ubc13-Uev1A
Substrate and enzymes for K48-linked chains: same protocol as for K63-linked chains but using 5e10 mMCdc34 instead of
Ubc13-Uev1A
Buffer: 50 mM TriseHCl (pH 8.0), 10 mM ATP, 4e10 mM MgCl2, and 0.6 mM DTT
[43]
K11 (Dong et al.) Same as K48 and K63 chains but using 30e50 mM UbE2SDC (M1-G156) as E2 [43]
K11 (Bremm et al.) Substrate and enzymes: 1.5 mM wild-type Ub, 250 nM E1, 4.8 mM UbE2SDC (last 25 aa truncated)
Buffer: 40 mM TriseHCl (pH 7.5), 10 mM ATP, 10 mM MgCl2, and 0.6 mM DTT
Total volume: 1 ml
For longer chains: 2.9 mM wild-type Ub, 250 nM E1, 4.8 mM UbE2S UBD; 400 nM AMSH added after 1.5 h
[44]
K6 (Hospenthal et al.) Substrate and enzymes: 25 mg of wild-type Ub, 2.91 mM, 0.1 mM E1, 0.56 mM UbE2L3, 11.1 mM NleL; OTUB1 added after
3 h
Buffer: 10 mM ATP and 10 mM MgCl2 in 40 mM TriseHCl (pH 7.5) and 0.6 mM DTT
Total volume: 1 ml
[31]
K33 (Kristariyanto et al.) Substrate and enzymes: 25 mg of wild-type Ub, 500 nM E1, 9 mM E2 UBE2D1 (UbcH5a), 6.3 mMAREL1; then added 20 mM
Cezanne EK (Cezanne E287K/E288K mutant), 5 mM OTUB1, and 5 mM DTT
Buffer: 50 mM TriseHCl (pH 7.5), 10 mM ATP, 10 mM MgCl2, and 0.6 mM DTT
Total volume: 1.5 ml
[54]
K33 (Michel et al.) Substrate and enzymes: 3 mM wild-type Ub, 1 mM E1, 10 mM E2 UBE2L3 (UbcH7), 36 mM AREL1; then treated with 1 mM
OTUB1*, 1 mM AMSH*, and 400 nM Cezanne
Buffer: 40 mM Tris (pH 8.5), 10 mM ATP, 10 mM MgCl2, 100 mM NaCl, 0.6 mM DTT, and 10% (v/v) glycerol
[56]
K29 (Kristariyanto et al.) Substrate and enzymes: 25 mg of wild-type Ub, 644 nM E1, 9.5 mM UBE2D3, 3 mM UBE3C; then added 2 mM vOTU and
5 mM DTT
Buffer: 10 mM ATP, 10 mM MgCl2, 50 mM TriseHCl (pH 7.5), and 0.6 mM DTT
Total volume: 1.5 ml
[55]
K29 (Michel et al.) Substrate and enzymes: 3 mM wild-type Ub, 1 mM E1, 10 mM UBE2L3 (UbcH7), 32 mM His-tagged SUMO UBE3C (aa 693
e1083)
Buffer: 10 mM ATP, 10 mM MgCl2, 40 mM Tris (pH 8.5), 100 mM NaCl, 0.6 mM DTT, and 10% (v/v) glycerol
[56]
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formation of chains having intermediate size, as demonstrated
previously by Komander and coworkers [44]. However, a speciﬁc
problem regarding K11-linked chains is that the ﬁdelity of the E2
enzyme used is not optimal. Thus, there is the possibility of
contemporary formation of different chain types (i.e., K63 chains)
in lower amounts [43]. No signiﬁcant difference was observed in
K11 linkage ﬁdelity for full-length UbE2S versus the UbE2SDC (M1-
G156) truncated mutant.
Komander and coworkers developed an alternative strategy for
the production of K11-linked tetraUb [44,52]. The authors found an
explanation for the reduced activity of wild-type UbE2S, namely
that the enzyme performs autoubiquitination in cis on its lysine-
rich C terminus. To avoid this inhibition, they exploited two ap-
proaches. One involves using a truncated version of UbE2S missing
the last 25 amino acids (so-called UbE2SDC, a slightly longer
construct than the truncated form used by Dong et al. [43]). The
second requires replacing the C terminus of the enzyme with the
Ub-binding domain (UBD) of IsoT to produce di-, tri-, and tetraUb
[44]. The UbE2S UBD fusion protein obtained is more active than
UbE2S toward the formation of K11 chains. However, this new
enzyme has reduced speciﬁcity, and contaminating K63-linked
chains can form. A DUB speciﬁc for K63-linked chains, AMSH, is
added to the reaction mixture to circumvent the problem.
Inmore details, the protocol for the production of diUb [44,52] is
similar to the one reported by Dong and coworkers [43]; the re-
action mixture includes wild-type Ub, E1, and UbE2SDC (last 25
amino acids truncated) reacted at 37 C for 10 h (Table 2). The
addition of 50 mM DTT is an alternative to stop the reaction before
dilution with 14 ml of 50 mM ammonium acetate at pH 4.5. The
puriﬁcation protocol requires cation exchange chromatography. For
longer chains, the more efﬁcient UbE2S UBD fusion protein is used
together with the DUB AMSH, which cleaves K63 chains. Tetramers
are synthesized by mixing Ub, E1, UbE2S UBD, and AMSH (Table 2).After 1.5 h at 37 C, AMSH is added again to cleave other K63 chains
eventually formed. After 3 h, 50 mM DTT is added to the reaction
before further dilution with 14 ml of 50 mM ammonium acetate
(pH 4.5). Lys11-linked di-, tri-, and tetraUb are puriﬁed by cation
exchange using a MonoS column (GE Life Sciences). The authors
also suggested using Lys11-linked diUb as input material to obtain
tetraUb [44].
Synthesis of K6-linked chains
The same conditions for the enzymatic reaction described earlier
(“Synthesis of K6-linked chains” section above) were used to obtain
wild-type K6-linked chains, substituting Ub K48Rwithwild-type Ub
(details shown in Table 2). After 3 h, OTUB1 was added to the
mixture and incubated overnight to cleave K48-linked chains [31].
Synthesis of K33-linked chains
Two similar protocols for large-scale enzymatic assembly of
K33-linked chains were recently published [54,56]. Ligation is
carried out by a HECT E3 ligase, AREL1 (also known as KIAA0317)
[61], which is shown to assemble K33-linked chains, together with
K11- and K48-linked chains and small amounts of K63 and K6
chains [56]. Speciﬁc DUBs, such as the Cezanne and OTUB1 DUBs or
their enhanced versions, are added to obtain pure K33-linked
chains after formation of a mixture of different chains. Cezanne
hydrolyzes K11-linked chains [62], whereas OTUB1 is active on K48
chains [48]. Alternatively, a modiﬁed version of AMSH could be
used to cleave K63-linked chains [56].
Kulathu and coworkers use a reaction volume containing wild-
type Ub, E1, E2 UBE2D1 (UbcH5a), and AREL1 at 30 C for 6 h [54]
(details shown in Table 2). They then add Cezanne EK (Cezanne
E287K/E288Kmutant), which hydrolyzes, together with K11-linked
chains, also K6, K48, and K63 linkages, OTUB1 and 5 mM DTT, and
Fig.5. Approach for the synthesis of K48-linked triUb using unnatural amino acids.
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50 mM sodium acetate, and K33-linked chains of deﬁned lengths
are puriﬁed by cation exchange using a Resource S 6-ml column (GE
Life Sciences) equilibrated with 50 mM sodium acetate (pH 4.5).
The chains are eluted in a gradient with 50 mM sodium acetate (pH
4.5) and 1 M NaCl.
According to Komander and coworkers, the K33-linked chains
are ﬁrst separated from the enzymes by acid precipitation before
the addition of the DUBs [56]. Cezanne and enhanced versions of
K48-speciﬁc OTUB1 (a UBE2D2eOTUB1 fusion named OTUB1*) and
of a K63-speciﬁc AMSH (a STAM2eAMSH fusion named AMSH*) are
used to cleave unwanted chains. In terms of protein production,
His-tagged SUMOeAREL1 (aa 436e823) is expressed in Rosetta
(DE3) pLacI cells and puriﬁed by afﬁnity chromatography. The tag is
removed by SUMO protease, and the enzyme is further puriﬁed by
anion exchange and size exclusion chromatography. OTUB1* and
AMSH* are puriﬁed by afﬁnity chromatography, followed by 3C
protease cleavage and ﬁnal puriﬁcation by size exclusion chroma-
tography. K33-linked chains are assembled using wild-type Ub, E1,
UBE2L3 (UbcH7), and AREL1 overnight at 37 C (Table 2). Glycerol
(10%, v/v) is used to avoid AREL1 precipitation. The enzymes are
precipitated in 0.25% (v/v) perchloric acid, and the chains are buffer
exchanged in 50mM Tris (pH 7.4), 150mMNaCl, and 4mMDTTand
treated with OTUB1*, AMSH*, and Cezanne for 1 h at 37 C. The
DUBs are then acid precipitated and the chains equilibrated in
50 mM sodium acetate (pH 4.5) and 5% (v/v) glycerol using a PD10
desalting column (GE Life Sciences). Cation exchange chromatog-
raphy on a MonoS column (GE Life Sciences) is used for the puri-
ﬁcation of K33-linked chains. A quantitative mass spectrometry
method (AQUA) [63] is used to assess the purity of the product [56].
The same technique has been used previously also for the assess-
ment of the K11-, K48-, and K63-linked chains [43].
Synthesis of K29-linked chains
Very recently, the same authors also independently described
similar protocols for the enzymatic production of K29-linked
chains [55,56]. They used another HECT E3 ligase, named UBE3C
(or HECTH2), able to form K29- and K48-linked chains [64]. Un-
wanted chains were cleaved by a combination of Cezanne, OTUB1*,
and AMSH* [56] or by the viral DUB vOTU [55].
Kulathu and coworkers noticed that UBE3C is also auto-
ubiquitylated in the reaction mixture, so the use of vOTU is
important to release free Ub species [55]. vOTU is able to cleave all
chain types except M1, K27, and K29 [65]. Proteins are expressed as
GST fusion and puriﬁed by afﬁnity chromatography, followed by tag
removal by C3 protease. GST UBE3C (aa 641e1083) is expressed in
insect cells using a baculovirus expression system. The assembly of
large-scale K29-linked chains is performed using wild-type Ub, E1,
UBE2D3, and UBE3C at 30 C overnight [55] (experimental condi-
tions in Table 2). vOTU and 5 mM DTT are added to the reaction
mixture and incubated further at 30 C overnight. Puriﬁcation is
identical to the one described for K33-linked chains.
Komander and coworkers use wild-type Ub, E1, UBE2L3
(UbcH7), His-tagged SUMO UBE3C (aa 693e1083) for an overnight
reaction at 37 C [56]. His-tagged SUMO UBE3C is expressed in
Rosetta 2 (DE3) pLacI cells as AREL1, and the protein is puriﬁed by
afﬁnity and size exclusion chromatography.
Controlled synthesis of Ub chains using unnatural amino
acids
Fushman's and Cropp's groups developed a method to produce
K11-linked diUb using a Ub substrate with modiﬁed lysines car-
rying genetically encoded removable protecting groups [45]. Themethod was ﬁrst applied to K48-linked chains and later used to
produce K11-linked diUb [30]. A pyrrolysyl-tRNA-synthetase/
tRNAPyl pair is used to add to the genetic code of E. coli a lysine
analogue in which the amino acid is protected with a tert-buty-
loxycarbonyl (Boc) group [66]. For the production of K48-linked
chains, a recombinant Ub containing a K48Lys(Boc) mutation is
produced in high yields and purity. This protein can be used,
similarly to Ub K48C, as a distally blocked Ub. This construct is then
reacted with a Ub mutant that is blocked on the proximal site (Ub-
D77 or Ub1e74, lacking the last two glycines) in the presence of E1
and E2-25K. K48-linked diUb is puriﬁed by size exclusion chro-
matography, and the Boc group is then cleaved by treatment with
2% triﬂuoroacetic acid. The dimer is equilibrated in the original
buffer. This method could be used for another step of polymeriza-
tion with Ub K48Lys(Boc) to form K48-linked triUb (Fig. 5). The
synthesis of fully natural K11-linked diUb was not described in
detail, but it is likely to be obtained on reaction of K11Lys(Boc) and
Ub-D77 in the presence of E1 and UbE2S, with subsequent cleavage
of the D77 residue by YUH1 [30].
Production of linear chains
The enzymes responsible for the formation of linear chains in
nature have been discovered and characterized (LUBAC for linear
ubiquitin chain assembly complex) [67], but the production of
milligrams of chains ismuch easier using a suitable plasmid for each
chain length required. Linear chains differ from the other chain
types because the covalent bond linking two Ub units is a proper
peptide bond, in that it connects the C-terminal glycine of one Ub
with the N-terminal methionine of the next one. For this reason,
linear chains can be easily prepared as a single polypeptide
construct from a plasmid coding for the wanted number of Ub
moieties. In 2008, Komander and coworkers constructed plasmids
for the expression of linear di-, tri-, and tetraUb [32]. Dong and co-
workers also reported a protocol for the production of linear chains
[43]. The synthetic genes are optimized for efﬁcient cloning and
expression in E. coli. The plasmids all contain a thrombin-cleavable
N-terminal His tag to facilitate puriﬁcation. A second step of size
exclusion chromatography is applied to obtain pure products.
Conclusions
We have reviewed here the most commonly used protocols for
the production of polyUb chains of different lengths and linkages.
S. Faggiano et al. / Analytical Biochemistry 492 (2016) 82e90 89As is clear from the above, several different approaches are
currently available, providing some ﬂexibility of choice within their
advantages and limitations. Nevertheless, the production of high
quantities of highly pure material remains a laborious task that
needs to be worked out and standardized. A clear shortfall is also
the lack of a protocol for the production of K27-linked Ub chains,
suggesting that more can still be done before the ﬁeld is completely
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